Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yacov Ashani

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Chemico-Biological Interactions|July 11, 2018
Catalytic bioscavengers as countermeasures against organophosphate nerve agentsMoshe Goldsmith, Yacov Ashani
Chemico-Biological Interactions|August 8, 2018
Corrigendum to "Catalytic bioscavengers as countermeasures against organophosphate nerve agents", [Chem. Biol. Interact. 292 (2018) 50-64]Moshe Goldsmith, Yacov Ashani
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2003
Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic modelYacov Ashani, Shlomi Pistinner
Toxicology and Applied Pharmacology|January 20, 2004
The effect of fluoride on the scavenging of organophosphates by human butyrylcholinesterase in buffer solutions and human plasmaYacov Ashani, Omri Segev, Ayala Balan
The Journal of Organic Chemistry|December 31, 2004
Probing the molecular interaction of chymotrypsin with organophosphorus compounds by 31P diffusion NMR in aqueous solutionsOmri Segev, Ishay Columbus, Yacov Ashani, et al.
Biochemical Pharmacology|June 27, 2003
Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivatorsYacov Ashani, Apurba K Bhattacharjee, Haim Leader, et al.
Protein Engineering, Design & Selection : PEDS|October 16, 2019
A mixture of three engineered phosphotriesterases enables rapid detoxification of the entire spectrum of known threat nerve agentsDragana Despotović, Einav Aharon, Artem Dubovetskyi, et al.
Molecular Pharmacology|March 10, 2007
The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamatesEfrat Groner, Yacov Ashani, Donna Schorer-Apelbaum, et al.
Biochemistry|January 1, 2009
Stabilization of Torpedo californica acetylcholinesterase by reversible inhibitorsLev Weiner, Valery L Shnyrov, Leonid Konstantinovskii, et al.
Chemico-Biological Interactions|June 4, 2016
A new post-intoxication treatment of paraoxon and parathion poisonings using an evolved PON1 variant and recombinant GOT1Moshe Goldsmith, Yacov Ashani, Raanan Margalit, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Chemico-Biological Interactions|July 11, 2018
Catalytic bioscavengers as countermeasures against organophosphate nerve agentsMoshe Goldsmith, Yacov Ashani
Chemico-Biological Interactions|August 8, 2018
Corrigendum to "Catalytic bioscavengers as countermeasures against organophosphate nerve agents", [Chem. Biol. Interact. 292 (2018) 50-64]Moshe Goldsmith, Yacov Ashani
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2003
Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic modelYacov Ashani, Shlomi Pistinner
Toxicology and Applied Pharmacology|January 20, 2004
The effect of fluoride on the scavenging of organophosphates by human butyrylcholinesterase in buffer solutions and human plasmaYacov Ashani, Omri Segev, Ayala Balan
The Journal of Organic Chemistry|December 31, 2004
Probing the molecular interaction of chymotrypsin with organophosphorus compounds by 31P diffusion NMR in aqueous solutionsOmri Segev, Ishay Columbus, Yacov Ashani, et al.
Biochemical Pharmacology|June 27, 2003
Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivatorsYacov Ashani, Apurba K Bhattacharjee, Haim Leader, et al.
Protein Engineering, Design & Selection : PEDS|October 16, 2019
A mixture of three engineered phosphotriesterases enables rapid detoxification of the entire spectrum of known threat nerve agentsDragana Despotović, Einav Aharon, Artem Dubovetskyi, et al.
Molecular Pharmacology|March 10, 2007
The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamatesEfrat Groner, Yacov Ashani, Donna Schorer-Apelbaum, et al.
Biochemistry|January 1, 2009
Stabilization of Torpedo californica acetylcholinesterase by reversible inhibitorsLev Weiner, Valery L Shnyrov, Leonid Konstantinovskii, et al.
Chemico-Biological Interactions|June 4, 2016
A new post-intoxication treatment of paraoxon and parathion poisonings using an evolved PON1 variant and recombinant GOT1Moshe Goldsmith, Yacov Ashani, Raanan Margalit, et al.
Pageof 4